Inflammasome and Atherogenesis

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|20|1|108-124

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.20, Iss.1, 2014-01, pp. : 108-124

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Role of Adipocytokines in Atherogenesis and Atheroprogression

By  

Current Drug Targets, Vol. 16, Iss. 4, 2015-04 ,pp. : 295-320

Bentham Science Publishers

Access to resources Recommend Favorite

Pneumococcal vaccine may prevent atherogenesis

By  

Inpharma, Vol. 1, Iss. 1395, 2003-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite

Inflammasome Signaling in Pathogenesis of Lung Diseases

By  

Current Pharmaceutical Design, Vol. 18, Iss. 16, 2012-06 ,pp. : 2320-2328

Bentham Science Publishers

Access to resources Recommend Favorite

Platelet Activation in Atherogenesis Associated with Low-Grade Inflammation

By  

Inflammation & Allergy-Drug Targets (Formerly Current Drug Targets - Inflammation & Allergy), Vol. 9, Iss. 5, 2010-12 ,pp. : 334-345

Bentham Science Publishers

Access to resources Recommend Favorite

The Role of Neopterin in Atherogenesis and Cardiovascular Risk Assessment

By  

Current Medicinal Chemistry, Vol. 16, Iss. 35, 2009-12 ,pp. : 4644-4653

Bentham Science Publishers

Access to resources Recommend Favorite